<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-12-39598</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0065778</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Cancer genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Cancer epidemiology</subject></subj-group></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancer risk factors</subject><subj-group><subject>Genetic causes of cancer</subject><subject>Predisposing conditions and syndromes</subject></subj-group></subj-group><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Lung and intrathoracic tumors</subject></subj-group></subj-group><subj-group><subject>Basic cancer research</subject></subj-group></subj-group><subj-group><subject>Pulmonology</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>The MPO−463G&gt;A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case–Control Studies</article-title>
<alt-title alt-title-type="running-head">The MPO−463G&gt;A Polymorphism and Lung Cancer Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Jun-Ping</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Wen-Bo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Xiao-Xi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ren</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>Fu-Xiang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Liu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Bai-Yu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhu</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>Huan-Gang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>Yun-Feng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Radiotherapy Oncology, The Third Affiliated Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Chemo-Radiotherapy Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, People’s Republic of China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>de Mello</surname><given-names>Ramon Andrade</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Porto, Portugal</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">yfzhouwhu@163.com</email></corresp>
<fn fn-type="conflict"><p>The authors declare that they have no conflict of interest.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: JPY YFZ. Performed the experiments: JPY WBW. Analyzed the data: JPY WBW XXY. Contributed reagents/materials/analysis tools: LY LR FXZ LH WH BYL YZ HGJ. Wrote the paper: JPY WBW XXY.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>20</day><month>6</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>6</issue>
<elocation-id>e65778</elocation-id>
<history>
<date date-type="received"><day>15</day><month>12</month><year>2012</year></date>
<date date-type="accepted"><day>28</day><month>4</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Yang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Myeloperoxidase (MPO) is an endogenous oxidant enzyme that produces reactive oxygen species (ROS) and may be involved in lung carcinogenesis. The MPO−463G&gt;A polymorphism influences MPO transcription and has been associated with lung cancer susceptibility. However, the association between the MPO−463G&gt;A polymorphism and lung cancer risk remains controversial.</p>
</sec><sec>
<title>Method</title>
<p>To investigate the effect of this polymorphism on lung cancer susceptibility, we performed a meta-analysis based on 22 published case–control studies including 7,520 patients with lung cancer and 8,600 controls. <bold>O</bold>dds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association.</p>
</sec><sec>
<title>Results</title>
<p>Overall, there was no evidence for significant association between MPO−463G&gt;A polymorphism and lung cancer susceptibility (for AA versus GG: OR = 0.91, 95%CI = 0.67–1.24; for GA versus GG: OR = 0.87, 95% CI = 0.78–0.98; for AA/GA versus GG: OR = 0.90, 95% CI = 0.80–1.01; for AA versus GA/GG: OR = 0.96, 95% CI = 0.72–1.28). In the stratified analyses by ethnicity, source of controls and smoking status, we also did not find any significant association between them.</p>
</sec><sec>
<title>Conclusions</title>
<p>In summary, this meta-analysis suggests MPO−463G&gt;A polymorphism may not be a risk factor for developing lung cancer. However, further prospective well-designed population-based studies with larger sample size are expected to validate the results.</p>
</sec></abstract>
<funding-group><funding-statement>This work was supported by the National Natural Science foundation of China (81071825/H1610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Lung cancer is one of the most common malignancies and the leading cause of cancer-related deaths in the United States and worldwide. It is estimated that in 2011, approximately 221,000 new cases will be diagnosed and 156,900 deaths due to lung cancer will occur in the United States <xref ref-type="bibr" rid="pone.0065778-Siegel1">[1]</xref>. The exact mechanism of lung carcinogenesis is still unclear. Lung cancer may be a multifactorial disease that resulted from complex interactions between genetic and environmental factors <xref ref-type="bibr" rid="pone.0065778-Pharoah1">[2]</xref>. It has been estimated that cigarette smoking is responsible for 85–90% of lung cancer development <xref ref-type="bibr" rid="pone.0065778-1">[3]</xref>. Although smoking can account for the majority of lung cancer, most chronic smokers still do not develop lung cancer. This suggests that lung cancer susceptibility differs among individuals and might have genetic factors which may influence the risk of lung cancer among these who are exposed to tobacco smoke carcinogens.</p>
<p>Myeloperoxidase (MPO) as an endogenous oxidant lysosomal enzyme available in polymorphonuclear neutrophils and monocytes catalyzes the reaction between the chloride ion and hydrogen peroxide and generates hypochlorous acid and other reactive oxygen species (ROS) <xref ref-type="bibr" rid="pone.0065778-Klebanoff1">[4]</xref>. The reactive by-products generated by MPO can cause oxidative damage in vivo to biomolecules, such as DNA, protein and lipids, and cause cellular alterations that may lead to carcinogenesis.</p>
<p>The human MPO gene located on chromosome 17q23.1 consists of 12 exons and 11 introns <xref ref-type="bibr" rid="pone.0065778-Austin1">[5]</xref> and there are at least 319 different polymorphism sites in the MPO gene (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP" xlink:type="simple">http://www.ncbi.nlm.nih.gov/projects/SNP</ext-link>). The most extensively studied single nucleotide polymorphism (SNP) was −463G&gt;A polymorphism (rs2333227) located in the promoter region of the MPO gene. Since Austin et al first published the MPO−463G&gt;A polymorphism in 1993 <xref ref-type="bibr" rid="pone.0065778-Austin1">[5]</xref>, many subsequent studies have consecutively reported the relationship between this polymorphism and different cancer types including esophagus, breast, bladder, brain and lung cancer and so forth. Among them, the relationship between lung cancer risk and the MPO−463G&gt;A polymorphism was the most extensively studied, It has been previously suggested that there was an association between the GG+GA genotype of MPO and a decreased risk of lung cancer <xref ref-type="bibr" rid="pone.0065778-Arslan1">[6]</xref>–<xref ref-type="bibr" rid="pone.0065778-London1">[10]</xref>. However, other studies have failed to confirm such the association <xref ref-type="bibr" rid="pone.0065778-Lu1">[8]</xref>, <xref ref-type="bibr" rid="pone.0065778-Klinchid1">[11]</xref>–<xref ref-type="bibr" rid="pone.0065778-Misra1">[24]</xref>. The exact relationship between MPO−463G&gt;A polymorphism and susceptibility to lung cancer is inconclusive or conflicting. Up to now, there have been two relevant published meta-analysis studies involving the MPO−463G&gt;A polymorphism and lung cancer risk <xref ref-type="bibr" rid="pone.0065778-Hua1">[25]</xref>, <xref ref-type="bibr" rid="pone.0065778-Chu1">[26]</xref>, among which one was published in Chinese and the other one was dealt with the meta-analysis on overall cancer susceptibilities. Unfortunately, those two meta-analyses all failed to adopt the most likely appropriate genetic model and lacked subgroups analyses such as smoking status and thus compromised the authentic values of statistical results. In addition, an increasing number of new studies between MPO−463G&gt;A polymorphism and lung cancer risk are available.</p>
<p>So it is necessary and significant to perform a meta-analysis to explore the association between the MPO−463G&gt;A polymorphism and lung cancer risk. Therefore, we performed a meta-analysis on all eligible case–control studies to estimate the overall lung cancer risk of MPO−463G&gt;A polymorphism and to quantify heterogeneity among the individual eligible studies.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Search Strategy</title>
<p>Eligible literatures published before the end of September 2012 were identified by the search of PUBMED, EMBASE, ISI Web of Science databases using combinations of the following keywords: “Myeloperoxidase”, “MPO”, “polymorphism” or “variant” and “lung cancer” or “lung carcinoma” without restriction on language. All relevant publications were reviewed. Articles in reference lists were also hand-searched for potentially relevant publications.</p>
</sec><sec id="s2b">
<title>Inclusion and Exclusion Criteria</title>
<p>Studies included had to meet all the following inclusion criteria: (a) the diagnosis of lung cancer patients were confirmed histologically or pathologically; (b) a case–control study on MPO−463G&gt;A polymorphism and lung cancer; (c) sufficient available data for estimating an odds ratios (ORs) with 95% confidence intervals (CIs). Major reasons for exclusion of studies were as follows: (i) not for lung cancer study, (ii) only case population and (iii) duplicate of previous publication.</p>
</sec><sec id="s2c">
<title>Data Extraction</title>
<p>Two investigators (JP Yang, B Wang) extracted the data independently including first author, year of publication, country, ethnicity (Caucasian, Asian and Mixed), source of controls (hospital-based studies, population-based studies), genotyping methods, matching variables, number of genotypes in cases and controls. Discrepancies were adjudicated by the third investigator (YF Zhou) until consensus was achieved on every item. Because two studies <xref ref-type="bibr" rid="pone.0065778-Skuladottir1">[7]</xref>, <xref ref-type="bibr" rid="pone.0065778-Klinchid1">[11]</xref> only provided the information of genotypes as “GG” and “AA/GA” without data for all three genotypes, we could only calculate the odds ratios (ORs) for the AA/GA versus GG model. We also abstracted the information of smoking status from available studies, and cigarette smoking status was strategically classified as never smokers, light smokers and heavy smokers.</p>
</sec><sec id="s2d">
<title>Statistical Analysis</title>
<p>For control group of each study, the allelic frequency was calculated and the observed genotype frequencies of the MPO−463G&gt;A polymorphism were assessed for Hardy-Weinberg equilibrium (HWE) by using the chi-square test. We calculated the strength of the association between MPO−463G&gt;A polymorphism and lung cancer risk by odds ratios (ORs) corresponding to 95% confidence intervals (CIs). The pooled ORs were performed for homozygote model (GA versus GG), heterozygote model (AA versus GG), dominant model (AA/GA versus GG) and recessive model (AA versus GA/GG) respectively. Stratified analyses were also performed by ethnicity, source of controls and smoking status respectively. Heterogeneity was evaluated with a chi-square-based Q test (<italic>P</italic>&lt;0.10 was considered significant) <xref ref-type="bibr" rid="pone.0065778-Higgins1">[27]</xref>. When heterogeneity was present, the random effects model was used to calculate the pooled ORs, whereas the fixed effects model was used <xref ref-type="bibr" rid="pone.0065778-DerSimonian1">[28]</xref>. Galbraith plot was used to determine the main sources of the heterogeneity <xref ref-type="bibr" rid="pone.0065778-Galbraith1">[29]</xref>, <xref ref-type="bibr" rid="pone.0065778-Bax1">[30]</xref>. The one-way sensitivity analyses were performed to assess the stability of the results, namely, a single study in the meta-analysis was deleted each time to reﬂect the inﬂuence of the individual data set to the pooled ORs <xref ref-type="bibr" rid="pone.0065778-Patsopoulos1">[31]</xref>. The publication bias of literatures was assessed using funnel plot and funnel plot asymmetry was assessed by the method of Egger’s linear regression test <xref ref-type="bibr" rid="pone.0065778-Begg1">[32]</xref>–<xref ref-type="bibr" rid="pone.0065778-Sterne1">[34]</xref>. The significance of the intercept was determined by the t test suggested by Egger and <italic>P</italic>&lt;0.05 was considered significant. All statistical analyses were performed with STATA software (version 12.0; STATA Corporation, College Station, TX), and all tests were two sided.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Study Characteristics</title>
<p>For lung cancer susceptibility related to MPO−463G&gt;A polymorphism, Study selection process was shown in <xref ref-type="fig" rid="pone-0065778-g001"><bold>Figure 1</bold></xref>. 22 case–control studies met the inclusion criteria including7,520 patients with lung cancer and 8,600 controls in this meta-analysis<xref ref-type="bibr" rid="pone.0065778-Arslan1">[6]</xref>–<xref ref-type="bibr" rid="pone.0065778-Misra1">[24]</xref>, <xref ref-type="bibr" rid="pone.0065778-Chan1">[35]</xref>–<xref ref-type="bibr" rid="pone.0065778-Marchand1">[37]</xref>. The characteristics of included studies and distribution of the frequencies of MPO−463G&gt;A polymorphism on lung cancer were summarized in <xref ref-type="table" rid="pone-0065778-t001"><bold>Table 1</bold></xref> and <xref ref-type="table" rid="pone-0065778-t002"><bold>Table 2</bold></xref> respectively. Overall, there were 9 studies of Caucasians, 6 studies of Asians, 7 of mixed population, and 11 studies of population-based, 11 studies of hospital-based. Six studies <xref ref-type="bibr" rid="pone.0065778-Lu1">[8]</xref>, <xref ref-type="bibr" rid="pone.0065778-Park1">[15]</xref>, <xref ref-type="bibr" rid="pone.0065778-Larsen1">[16]</xref>, <xref ref-type="bibr" rid="pone.0065778-Harms1">[18]</xref>, <xref ref-type="bibr" rid="pone.0065778-Feyler1">[22]</xref>, <xref ref-type="bibr" rid="pone.0065778-Dally1">[23]</xref> collected the information on possible confounding factors like smoking status. All cases were pathologically confirmed and Almost controls were mainly matched for age and sex. Most polymorphisms in the control subjects were in Hardy–Weinberg equilibrium.</p>
<fig id="pone-0065778-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.g001</object-id><label>Figure 1</label><caption>
<title>Flow chart of study selection based on the inclusion and exclusion criteria.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0065778-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.t001</object-id><label>Table 1</label><caption>
<title>Main characteristics of studies included in the meta-analysis.</title>
</caption><alternatives><graphic id="pone-0065778-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Control source</td>
<td align="left" rowspan="1" colspan="1">Genotyping method</td>
<td align="left" rowspan="1" colspan="1">Matching</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Arslan</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Klinchid</td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Thailand</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yoon</td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">age</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zienolddiny</td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Norway</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yang</td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Larsen</td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Park</td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chan</td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Skuladottir</td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Denmark</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Harms</td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu</td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chevrier</td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">France</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">age</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dally, H</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Feyler</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">France</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kantarci</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">sex and ethnicity</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lu</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Schabath</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age,sex and ethnicity</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Xu</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Misra</td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Finland</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">age</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cascorbi</td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age and sex</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Marchand</td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age,sex and ethnicity</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">London</td>
<td align="left" rowspan="1" colspan="1">1997</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Mixed</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">PCR–RFLP</td>
<td align="left" rowspan="1" colspan="1">age,sex and ethnicity</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p><italic>Abbreviations</italic> HB: Hospital-based studies; PB: Population-based studies; PCR-RFLP: Polymerase chain reaction–restriction fragment length polymorphism; NA: Not available.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0065778-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.t002</object-id><label>Table 2</label><caption>
<title>Distribution of MPO−463G&gt;A polymorphism among lung cancer cases and controls included in the meta-analysis.</title>
</caption><alternatives><graphic id="pone-0065778-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td colspan="2" align="left" rowspan="1">Sample size</td>
<td colspan="3" align="left" rowspan="1">cases</td>
<td colspan="3" align="left" rowspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> for HWE</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cases</td>
<td align="left" rowspan="1" colspan="1">Controls</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">GA</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">GA</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Arslan</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">106</td>
<td align="left" rowspan="1" colspan="1">271</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">136</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Klinchid</td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">81</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td colspan="2" align="left" rowspan="1">29<sup> a</sup></td>
<td align="left" rowspan="1" colspan="1">57</td>
<td colspan="2" align="left" rowspan="1">24<sup> a</sup></td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yoon</td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">213</td>
<td align="left" rowspan="1" colspan="1">213</td>
<td align="left" rowspan="1" colspan="1">180</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">175</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.42</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zienolddiny</td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">258</td>
<td align="left" rowspan="1" colspan="1">297</td>
<td align="left" rowspan="1" colspan="1">150</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">179</td>
<td align="left" rowspan="1" colspan="1">109</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yang</td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">318</td>
<td align="left" rowspan="1" colspan="1">353</td>
<td align="left" rowspan="1" colspan="1">269</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">283</td>
<td align="left" rowspan="1" colspan="1">68</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Larsen</td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">627</td>
<td align="left" rowspan="1" colspan="1">624</td>
<td align="left" rowspan="1" colspan="1">382</td>
<td align="left" rowspan="1" colspan="1">205</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">383</td>
<td align="left" rowspan="1" colspan="1">210</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Park</td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">432</td>
<td align="left" rowspan="1" colspan="1">432</td>
<td align="left" rowspan="1" colspan="1">353</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">356</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.87</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chan</td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">162</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0.41</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Skuladottir</td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">122</td>
<td align="left" rowspan="1" colspan="1">396</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td colspan="2" align="left" rowspan="1">47<sup> a</sup></td>
<td align="left" rowspan="1" colspan="1">270</td>
<td colspan="2" align="left" rowspan="1">126<sup> a</sup></td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Harms</td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">119</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu</td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">830</td>
<td align="left" rowspan="1" colspan="1">1119</td>
<td align="left" rowspan="1" colspan="1">490</td>
<td align="left" rowspan="1" colspan="1">296</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">692</td>
<td align="left" rowspan="1" colspan="1">386</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">0.15</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chevrier</td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">243</td>
<td align="left" rowspan="1" colspan="1">245</td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">140</td>
<td align="left" rowspan="1" colspan="1">93</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dally, H</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">625</td>
<td align="left" rowspan="1" colspan="1">340</td>
<td align="left" rowspan="1" colspan="1">429</td>
<td align="left" rowspan="1" colspan="1">173</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">218</td>
<td align="left" rowspan="1" colspan="1">105</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Feyler</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">150</td>
<td align="left" rowspan="1" colspan="1">172</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">42</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">96</td>
<td align="left" rowspan="1" colspan="1">63</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.55</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kantarci</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">307</td>
<td align="left" rowspan="1" colspan="1">307</td>
<td align="left" rowspan="1" colspan="1">192</td>
<td align="left" rowspan="1" colspan="1">106</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">181</td>
<td align="left" rowspan="1" colspan="1">111</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lu</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">314</td>
<td align="left" rowspan="1" colspan="1">320</td>
<td align="left" rowspan="1" colspan="1">248</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">227</td>
<td align="left" rowspan="1" colspan="1">87</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.48</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Schabath</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">375</td>
<td align="left" rowspan="1" colspan="1">378</td>
<td align="left" rowspan="1" colspan="1">235</td>
<td align="left" rowspan="1" colspan="1">126</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">202</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">0.10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Xu</td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">989</td>
<td align="left" rowspan="1" colspan="1">1128</td>
<td align="left" rowspan="1" colspan="1">599</td>
<td align="left" rowspan="1" colspan="1">343</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">697</td>
<td align="left" rowspan="1" colspan="1">390</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Misra</td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">315</td>
<td align="left" rowspan="1" colspan="1">311</td>
<td align="left" rowspan="1" colspan="1">191</td>
<td align="left" rowspan="1" colspan="1">108</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">206</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">&lt;0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cascorbi</td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">196</td>
<td align="left" rowspan="1" colspan="1">196</td>
<td align="left" rowspan="1" colspan="1">141</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">117</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Marchand</td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">323</td>
<td align="left" rowspan="1" colspan="1">437</td>
<td align="left" rowspan="1" colspan="1">234</td>
<td align="left" rowspan="1" colspan="1">77</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">294</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">&lt;0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">London</td>
<td align="left" rowspan="1" colspan="1">1997</td>
<td align="left" rowspan="1" colspan="1">339</td>
<td align="left" rowspan="1" colspan="1">703</td>
<td align="left" rowspan="1" colspan="1">353</td>
<td align="left" rowspan="1" colspan="1">136</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">401</td>
<td align="left" rowspan="1" colspan="1">243</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p><italic>Abbreviations</italic> HWE: Hardy–Weinberg Equilibrium; NA: not applicable; a: number of GA+AA.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Meta-analysis Results</title>
<p><xref ref-type="table" rid="pone-0065778-t003"><bold>Table 3</bold></xref> listed the results of the association between the MPO−463G&gt;A polymorphism and lung cancer risk. Overall, there was no evidence for significant association between MPO−463G&gt;A polymorphism and lung cancer susceptibility (for AA versus GG: OR = 0.91, 95%CI = 0.67–1.24; for AA/GA versus GG: OR = 0.90, 95%CI = 0.80–1.01; for AA versus GA/GG: OR = 0.96, 95%CI = 0.72–1.28) (<xref ref-type="fig" rid="pone-0065778-g002"><bold>Figure 2</bold></xref>). In the stratified analysis by ethnicity, source of controls and smoking status, we also did not find any significant association between MPO−463G&gt;A polymorphism and lung cancer risk. MPO −463G&gt;A polymorphism was a low protective susceptibility gene in lung cancer development in homozygote model (for GA versus GG: OR = 0.87, 95%CI = 0.78–0.98), however, when stratified by ethnicity, source of controls and smoking status, we also did not find any significant association between them (for Caucasian population: OR = 0.86, 95%CI = 0.71–1.05, for Asian population: OR = 0.92, 95%CI = 0.67–1.25, for mixed population: OR = 0.86, 95%CI = 0.73–1.02, for population-based studies: OR = 0.87, 95%CI = 0.74–1.03, for hospital-based studies: OR = 0.87, 95%CI = 0.74–1.02, for never smokers: OR = 0.77, 95%CI = 0.43–1.38, for light smokers: OR = 1.00, 95%CI = 0.79–1.27, for heavy smokers: OR = 0.92, 95% CI = 0.69–1.23).</p>
<fig id="pone-0065778-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.g002</object-id><label>Figure 2</label><caption>
<title>Forest plots of lung cancer risk associated with the MPO−463G&gt;A polymorphism for AA/GA versus GG model in the stratified analyses by ethnicities.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0065778-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.t003</object-id><label>Table 3</label><caption>
<title>Meta-analyses of the MPO −463G&gt;A polymorphism on lung cancer risk.</title>
</caption><alternatives><graphic id="pone-0065778-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Subgroup</td>
<td align="left" rowspan="1" colspan="1">Number</td>
<td colspan="2" align="left" rowspan="1">AA versus GG(heterozygote)</td>
<td colspan="2" align="left" rowspan="1">GA versus GG(homozygote)</td>
<td colspan="2" align="left" rowspan="1">AA/GA versus GG (dominant)</td>
<td colspan="2" align="left" rowspan="1">AA versus GA/GG (recessive)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">N/Cases/Controls</td>
<td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P<sub>value</sub>/P<sub>het</sub></italic></td>
<td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P<sub>value</sub>/P<sub>het</sub></italic></td>
<td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P<sub>value</sub>/P<sub>het</sub></italic></td>
<td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P<sub>value</sub>/P<sub>het</sub></italic></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Total</bold></td>
<td align="left" rowspan="1" colspan="1">22/7520/8600</td>
<td align="left" rowspan="1" colspan="1">0.91(0.67,1.24)</td>
<td align="left" rowspan="1" colspan="1">0.56/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.87(0.78,0.98)</td>
<td align="left" rowspan="1" colspan="1">0.02/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.90(0.80,1.01)</td>
<td align="left" rowspan="1" colspan="1">0.07/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.96(0.72,1.28)</td>
<td align="left" rowspan="1" colspan="1">0.77/&lt;0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Ethnicity</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Caucasian</bold></td>
<td align="left" rowspan="1" colspan="1">9/2642/2848</td>
<td align="left" rowspan="1" colspan="1">1.03(0.64,1.67)</td>
<td align="left" rowspan="1" colspan="1">0.89/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.86(0.71,1.05)</td>
<td align="left" rowspan="1" colspan="1">0.13/0.02</td>
<td align="left" rowspan="1" colspan="1">0.92(0.77,1.11)</td>
<td align="left" rowspan="1" colspan="1">0.38/0.01</td>
<td align="left" rowspan="1" colspan="1">1.09(0.67,1.76)</td>
<td align="left" rowspan="1" colspan="1">0.74/&lt;0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Asian</bold></td>
<td align="left" rowspan="1" colspan="1">6/1440/1561</td>
<td align="left" rowspan="1" colspan="1">0.92(0.46,1.85)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.82/0.46</td>
<td align="left" rowspan="1" colspan="1">0.92(0.67,1.25)</td>
<td align="left" rowspan="1" colspan="1">0.59/0.04</td>
<td align="left" rowspan="1" colspan="1">0.95(0.71,1.26)</td>
<td align="left" rowspan="1" colspan="1">0.70/0.04</td>
<td align="left" rowspan="1" colspan="1">0.95(0.47,1.90)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.87/0.56</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Mixed</bold></td>
<td align="left" rowspan="1" colspan="1">7/3439/4191</td>
<td align="left" rowspan="1" colspan="1">0.79(0.47,1.33)</td>
<td align="left" rowspan="1" colspan="1">0.38/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.86(0.73,1.02)</td>
<td align="left" rowspan="1" colspan="1">0.09/0.01</td>
<td align="left" rowspan="1" colspan="1">0.84(0.68,1.04)</td>
<td align="left" rowspan="1" colspan="1">0.11/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.84(0.53,1.33)</td>
<td align="left" rowspan="1" colspan="1">0.46/&lt;0.01</td>
</tr>
<tr>
<td colspan="2" align="left" rowspan="1"><bold>Study design</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>PB</bold></td>
<td align="left" rowspan="1" colspan="1">11/4085/5310</td>
<td align="left" rowspan="1" colspan="1">0.96(0.58,1.60)</td>
<td align="left" rowspan="1" colspan="1">0.87/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.87(0.74,1.03)</td>
<td align="left" rowspan="1" colspan="1">0.10/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">0.91(0.76,1.09)</td>
<td align="left" rowspan="1" colspan="1">0.28/&lt;0.01</td>
<td align="left" rowspan="1" colspan="1">1.00(0.62,1.64)</td>
<td align="left" rowspan="1" colspan="1">0.99/&lt;0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>HB</bold></td>
<td align="left" rowspan="1" colspan="1">11/3436/3290</td>
<td align="left" rowspan="1" colspan="1">0.88(0.67,1.14)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.32/0.46</td>
<td align="left" rowspan="1" colspan="1">0.87(0.74,1.02)</td>
<td align="left" rowspan="1" colspan="1">0.09/0.03</td>
<td align="left" rowspan="1" colspan="1">0.88(0.75,1.03)</td>
<td align="left" rowspan="1" colspan="1">0.11/0.03</td>
<td align="left" rowspan="1" colspan="1">0.92(0.71,1.20)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.54/0.58</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Smoking status</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Never smokers</bold></td>
<td align="left" rowspan="1" colspan="1">2/174/709</td>
<td align="left" rowspan="1" colspan="1">1.07(0.23,5.00)</td>
<td align="left" rowspan="1" colspan="1">0.93/NA</td>
<td align="left" rowspan="1" colspan="1">0.77(0.43,1.38)</td>
<td align="left" rowspan="1" colspan="1">0.38/NA</td>
<td align="left" rowspan="1" colspan="1">0.79(0.54,1.14)</td>
<td align="left" rowspan="1" colspan="1">0.21/NA</td>
<td align="left" rowspan="1" colspan="1">1.17(0.25,5.40)</td>
<td align="left" rowspan="1" colspan="1">0.84/NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Light smokers</bold></td>
<td align="left" rowspan="1" colspan="1">6/825/943</td>
<td align="left" rowspan="1" colspan="1">1.05(0.60,1.84)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.86/0.83</td>
<td align="left" rowspan="1" colspan="1">1.00(0.79,1.27)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.98/0.37</td>
<td align="left" rowspan="1" colspan="1">0.92(0.74,1.13)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.41/0.18</td>
<td align="left" rowspan="1" colspan="1">1.07(0.62,1.86)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.81/0.84</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Heavy smokers</bold></td>
<td align="left" rowspan="1" colspan="1">5/744/688</td>
<td align="left" rowspan="1" colspan="1">1.39(0.75,2.60)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.30/0.85</td>
<td align="left" rowspan="1" colspan="1">0.92(0.69,1.23)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.57/0.60</td>
<td align="left" rowspan="1" colspan="1">0.82(0.66,1.03)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.09/0.21</td>
<td align="left" rowspan="1" colspan="1">1.58(0.86,2.90)<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">0.15/0.47</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p><italic>Abbreviations</italic> N:Number of studies; NA: Not applicable; <italic>P<sub>het</sub></italic> : Probability of heterogeneity; a: Fixed-effects model was used when <bold><italic>P<sub>het</sub></italic></bold>≥0.1, otherwise, random model was used.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c">
<title>Test of Heterogeneity</title>
<p>Significant heterogeneity existed in four genetic models of the MPO−463G&gt;A polymorphism (AA versus GG, GA versus GG, AA/GA versus GG, AA versus GA/GG) (<xref ref-type="table" rid="pone-0065778-t003"><bold>Table 3</bold></xref>). Galbraith plot analyses of all included studies were used to assess the potential sources of heterogeneity. Chan, Liu and London’s studies <xref ref-type="bibr" rid="pone.0065778-London1">[10]</xref>, <xref ref-type="bibr" rid="pone.0065778-Chan1">[35]</xref> were found to be the main contributors of heterogeneity in the AA/GA versus GG model (<xref ref-type="fig" rid="pone-0065778-g003"><bold>Figure 3</bold></xref>). The significance of pooled ORs with 95%CIs in the AA/GA versus GG model in both overall comparison and subgroup analyses was not influenced by omitting those three studies (Data not shown).</p>
<fig id="pone-0065778-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.g003</object-id><label>Figure 3</label><caption>
<title>Galbraith plot analysis of the amount of heterogeneity from all the included studies (AA/GA versus GG).</title>
<p>The Y-axis shows the ratio of the log OR to its standard error (SE), and the x-axis shows the reciprocal of the SE. At a 2 standard deviation distance parallel to the regression line, the 2 lines create an interval. Studies lacking in heterogeneity would lie within the 95% confidence interval.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>Sensitivity Analysis</title>
<p>Sensitivity analysis was performed through sequentially excluding individual studies. Statistically similar results were obtained after sequentially excluding each study in GA/AA versus GG model (<xref ref-type="fig" rid="pone-0065778-g004"><bold>Figure 4</bold></xref>) and the corresponding pooled ORs in the other genetic models were not materially altered (Data not shown), suggesting stability and liability of this meta-analysis.</p>
<fig id="pone-0065778-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.g004</object-id><label>Figure 4</label><caption>
<title>Sensitivity analysis conducted to assess the influence of each study on the pooled ORs by individual studies omission in AA/GA versus GG model.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Publication Bias</title>
<p>The funnel plot and Egger’s test did not provide any obvious evidence of publication bias that examined the MPO−463G&gt;A polymorphism and lung cancer risk. The shape of funnel plots did not reveal any evidence of funnel plot asymmetry (<xref ref-type="fig" rid="pone-0065778-g005"><bold>Figure 5</bold></xref>), Egger's test further provided statistical evidence of funnel plot symmetry for AA versus GG (<italic>P</italic> = 0.55), GA versus GG (<italic>P</italic> = 0.27), AA/GA versus GG (<italic>P</italic> = 0.56) and for AA versus GA/GG (<italic>P</italic> = 0.61).</p>
<fig id="pone-0065778-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065778.g005</object-id><label>Figure 5</label><caption>
<title>Begg’s funnel plot between the MPO−463G&gt;A polymorphism and lung cancer risk in AA/GA versus GG model.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065778.g005" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>As we all know, lung cancer is a complex multifactorial and multistage process, in which both host genetic factors and environmental factors are involved <xref ref-type="bibr" rid="pone.0065778-Pharoah1">[2]</xref>. Individual genetic susceptibility has been suggested to correlate with lung cancer risk. In the current meta-analysis, on the basis of 22 case-control studies providing the information on the MPO−463G&gt;A polymorphism and lung cancer involving 7,520 cases and 8,600 controls, we did not find any significant association between the MPO−463G&gt;A polymorphism and lung cancer risk in any genetic model and also the similar results stratified by ethnicity, source of controls and smoking status respectively. The one-way sensitivity analyses suggested the stability and liability of the results in this meta-analysis. Publication bias was not observed in this study. Our meta-analysis suggests that the MPO −463G&gt;A polymorphism is not associated with lung cancer development.</p>
<p>Oxidative stress occurs when the excessive production of reactive oxygen species (ROS) overwhelms the antioxidant defense system. Increasing evidences suggests variability in these genes involved in oxidative stress may determine the level of oxidative stress in the organism and play a crucial role in carcinogenesis <xref ref-type="bibr" rid="pone.0065778-Klebanoff1">[4]</xref>, <xref ref-type="bibr" rid="pone.0065778-Austin1">[5]</xref>. Therefore, it is rational to speculate that certain genetic variants or polymorphisms in the genes involved in oxidative stress may have an impact on cancer risk. MPO is an endogenous oxidant enzyme that generates reactive oxygen species (ROS) that may be involved in carcinogenesis <xref ref-type="bibr" rid="pone.0065778-Klebanoff1">[4]</xref>, <xref ref-type="bibr" rid="pone.0065778-Feig1">[38]</xref>. MPO−463G&gt;A polymorphism was located in the promoter region of the MPO gene. The G allele acts as a strong stimulatory protein 1 (SP1) transcription factors binding site, which reacts with SP1 to elevate MPO transcriptional activity <xref ref-type="bibr" rid="pone.0065778-Piedrafita1">[39]</xref>. Therefore the guanosine (G) to adenosine (A) nucleotide base substitution is associated with disruption of the SP1 binding site and thus reduces 25 times MPO gene expression and decreases the enzyme levels. So it is biologically plausible that MPO−463G&gt;A polymorphism may modulate the risk of lung cancer. Therefore, many studies have investigated the role of MPO−463G&gt;A polymorphism in the pathogenesis of lung cancer <xref ref-type="bibr" rid="pone.0065778-Arslan1">[6]</xref>–<xref ref-type="bibr" rid="pone.0065778-Misra1">[24]</xref>, <xref ref-type="bibr" rid="pone.0065778-Chan1">[35]</xref>–<xref ref-type="bibr" rid="pone.0065778-Marchand1">[37]</xref>. However, the results remain conﬂicting rather than conclusive. There are several possible explanations for this discordance, such as small sample size, ethnic background, uncorrected multiple hypothesis testing, and publication bias. Meta-analysis is a statistical procedure for combining the results of several studies to produce a single estimate of the major effect with enhanced precision. So we performed a meta-analysis on 22 eligible case–control studies to estimate the overall lung cancer risk of MPO−463G&gt;A polymorphism, whereas no significant associations were found between them in any genetic model in this meta-analysis.</p>
<p>Population stratification is an area of concern that can lead to spurious evidence for the association between a marker and cancer and suggest a possible role for ethnic differences in genetic backgrounds.</p>
<p>Previous studies have found a wide variation in the A allele frequency of the MPO−463G&gt;A polymorphism across different ethnicities. The −463A allele frequency was 22.8% in European population, but approximately 14.7% in Asian population <xref ref-type="bibr" rid="pone.0065778-Chu2">[40]</xref>. When stratified according to ethnicity in this meta-analysis study, no significant associations were found in any of the genetic models in the Caucasian, Asian and mixed population. Although hospital-based studies may have inherent selection biases, we also did not find any positive result in the stratified analyses by population-based and hospital-based studies. These results suggested that the different ethnicities and source of controls did not influence the association between the MPO−463G&gt;A polymorphism and lung cancer risk.</p>
<p>Lung cancer have been characterized as causally related to cigarette smoking <xref ref-type="bibr" rid="pone.0065778-2">[41]</xref>. MPO transforms tobacco smoke procarcinogens, such as benzo(α)pyrene and arylamines, into highly carcinogenic intermediates, such as benzo(α)pyrene dio-epoxide. Since MPO−463G&gt;A polymorphism may be associated with weaker transcriptional activity and decreases the enzyme levels, carcinogens contained in cigarette smoking will not be metabolically activated by MPO enzyme, therefore this polymorphism has been suggested to have a protective effect against the development of cancers related to smoking such as lung cancer <xref ref-type="bibr" rid="pone.0065778-VanHelden1">[42]</xref>, <xref ref-type="bibr" rid="pone.0065778-VanSchooten1">[43]</xref>. Whereas in our meta-analysis study, the MPO−463G&gt;A polymorphism was shown to have no statistically significant protective effect in light smokers and heavy smokers. The exact mechanism for this inverse result was not clear. That may be due to the limited number of study subjects related to smoking which may have low power of statistical test, so further large-scale researches between MPO−463G&gt;A polymorphism and risk of lung cancer in smokers are expected to confirm the results.</p>
<p>Several limitations of this meta-analysis should be addressed. First, when interpreting the results of this meta-analysis, heterogeneity was a potential problem and the origins of heterogeneity may include many factors, such as the differences in control characteristics and diverse genotyping methods; Second, the lack of detailed information such as age, sex and lifestyle of the patients in some studies, limited further stratification, and more accurate ORs would be corrected for age, sex and other factors that were associated with lung cancer risk. Nevertheless, our meta-analysis has some advantages. First, the well-designed search and selection method significantly increased the statistical power of this meta-analysis. Second, we could perform a subgroup analysis to address a possible interaction between smoking parameters and MPO−463G&gt;A polymorphism. Third, the results did not show any evidence of publication bias.</p>
<p>In summary, our meta-analysis suggests that the MPO −463G&gt;A polymorphism may not be a risk factor for lung cancer. However, lung cancer may be a multifactorial disease that resulted from complex interactions between genetic and environmental factors, we could not collect the detailed original data of MPO gene polymorphisms and then we were not able to investigate potential gene-gene, gene- environment interactions. Further prospective researches using adjusted individual data with large sample studies which study the relationship between MPO−463G&gt;A polymorphism and the risk of lung cancer are necessary and expected, which would lead a better, comprehensive understanding of the association between MPO−463G&gt;A polymorphism and lung cancer risk.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0065778.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0065778.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p>MOOSE Checklist.</p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0065778-Siegel1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Brawley</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths</article-title>. <source>CA Cancer J Clin</source> <volume>61</volume>: <fpage>212</fpage>–<lpage>236</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Pharoah1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pharoah</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Dunning</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ponder</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Easton</surname><given-names>DF</given-names></name> (<year>2004</year>) <article-title>Association studies for finding cancer-susceptibility genetic variants</article-title>. <source>Nat Rev Cancer</source> <volume>4</volume>: <fpage>850</fpage>–<lpage>860</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-1"><label>3</label>
<mixed-citation publication-type="book" xlink:type="simple">(2004) The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta GA.</mixed-citation>
</ref>
<ref id="pone.0065778-Klebanoff1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klebanoff</surname><given-names>SJ</given-names></name> (<year>1999</year>) <article-title>Myeloperoxidase</article-title>. <source>Proc Assoc Am Physicians</source> <volume>111</volume>: <fpage>383</fpage>–<lpage>389</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Austin1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Austin</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Hodge</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Sequence comparison of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells</article-title>. <source>Leukemia</source> <volume>7</volume>: <fpage>1445</fpage>–<lpage>1450</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Arslan1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arslan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pinarbasi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Silig</surname><given-names>Y</given-names></name> (<year>2011</year>) <article-title>Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population</article-title>. <source>Molecular Medicine Reports</source> <volume>4</volume>: <fpage>87</fpage>–<lpage>92</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Skuladottir1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skuladottir</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Autrup</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Autrup</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tjoenneland</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Overvad</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years: A pooled study of lung cancer patients in Denmark and Norway</article-title>. <source>Lung Cancer</source> <volume>48</volume>: <fpage>187</fpage>–<lpage>199</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Lu1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Lung cancer risk associated with genetic polymorphism in myeloperoxidase (-463 G/A) in a Chinese population</article-title>. <source>Zhonghua zhong liu za zhi [Chinese journal of oncology]</source> <volume>24</volume>: <fpage>250</fpage>–<lpage>253</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Cascorbi1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cascorbi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Henning</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brockmoller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gephart</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meisel</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant–463A of the myeloperoxidase gene</article-title>. <source>Cancer Res</source> <volume>60</volume>: <fpage>644</fpage>–<lpage>649</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-London1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>London</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Lehman</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>JA</given-names></name> (<year>1997</year>) <article-title>Myeloperoxidase genetic polymorphism and lung cancer risk</article-title>. <source>Cancer Research</source> <volume>57</volume>: <fpage>5001</fpage>–<lpage>5003</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Klinchid1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klinchid</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chewaskulyoung</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Saeteng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lertprasertsuke</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kasinrerk</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women</article-title>. <source>Cancer Genetics and Cytogenetics</source> <volume>195</volume>: <fpage>143</fpage>–<lpage>149</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Zienolddiny1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zienolddiny</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Campa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lind</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ryberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Skaug</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers</article-title>. <source>Carcinogenesis</source> <volume>29</volume>: <fpage>1164</fpage>–<lpage>1169</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Yoon1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoon</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Gil</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hwangbo</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>CyP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women</article-title>. <source>Lung Cancer</source> <volume>60</volume>: <fpage>40</fpage>–<lpage>46</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Yang1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hwangbo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name> (<year>2007</year>) <article-title>Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility</article-title>. <source>Lung Cancer</source> <volume>57</volume>: <fpage>135</fpage>–<lpage>142</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Park1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Cha</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>EB</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Myeloperoxidase -463G&gt;A polymorphism and risk of primary lung cancer in a Korean population</article-title>. <source>Cancer Detection and Prevention</source> <volume>30</volume>: <fpage>257</fpage>–<lpage>261</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Larsen1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsen</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Colosimo</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zimmerman</surname><given-names>PV</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung</article-title>. <source>Carcinogenesis</source> <volume>27</volume>: <fpage>525</fpage>–<lpage>532</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Liu1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>DP</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma</article-title>. <source>Cancer Letters</source> <volume>214</volume>: <fpage>69</fpage>–<lpage>79</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Harms1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harms</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Salama</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sierra-Torres</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Cajas-Salazar</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Au</surname><given-names>WW</given-names></name> (<year>2004</year>) <article-title>Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer</article-title>. <source>Environmental and Molecular Mutagenesis</source> <volume>44</volume>: <fpage>74</fpage>–<lpage>82</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Chevrier1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chevrier</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Stucker</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Houllier</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Cenee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Beaune</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Myeloperoxidase: new polymorphisms and relation with lung cancer risk</article-title>. <source>Pharmacogenetics</source> <volume>13</volume>: <fpage>729</fpage>–<lpage>739</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Schabath1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schabath</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Spitz</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Delclos</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>WF</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>A myeloperoxidase polymorphism associated with reduced risk of lung cancer</article-title>. <source>Lung Cancer</source> <volume>37</volume>: <fpage>35</fpage>–<lpage>40</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Kantarci1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kantarci</surname><given-names>OH</given-names></name>, <name name-style="western"><surname>Lesnick</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hebrink</surname><given-names>DD</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Myeloperoxidase -463 (G–&gt;A) polymorphism associated with lower risk of lung cancer</article-title>. <source>Mayo Clin Proc</source> <volume>77</volume>: <fpage>17</fpage>–<lpage>22</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Feyler1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feyler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Voho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bouchardy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuokkanen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dayer</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Point: Myeloperoxidase (-463)G -&gt; A polymorphism and lung cancer risk</article-title>. <source>Cancer Epidemiology Biomarkers &amp; Prevention</source> <volume>11</volume>: <fpage>1550</fpage>–<lpage>1554</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Dally1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dally</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gassner</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jager</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schmezer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Spiegelhalder</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Myeloperoxidase (MPO) genotype and lung cancer histologic types: The MPO-463 A allele is associated with reduced risk for small cell lung cancer in smokers</article-title>. <source>International Journal of Cancer</source> <volume>102</volume>: <fpage>530</fpage>–<lpage>535</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Misra1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Misra</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Tangrea</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Virtamo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ratnasinghe</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>MR</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland</article-title>. <source>Cancer Letters</source> <volume>164</volume>: <fpage>161</fpage>–<lpage>167</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Hua1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hua</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A meta analysis on the relationship between myeloperoxidase G-463A genetic polymorphisms and lung cancer susceptibility</article-title>. <source>Chinese Journal of Lung Cancer</source> <volume>13</volume>: <fpage>122</fpage>–<lpage>127</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Chu1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>DY</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>DM</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The MPO-463G&gt;A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies</article-title>. <source>Mutagenesis</source> <volume>25</volume>: <fpage>389</fpage>–<lpage>395</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Higgins1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name> (<year>2002</year>) <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-DerSimonian1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Galbraith1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galbraith</surname><given-names>RF</given-names></name> (<year>1988</year>) <article-title>A note on graphical presentation of estimated odds ratios from several clinical trials</article-title>. <source>Statistics in Medicine</source> <volume>7</volume>: <fpage>889</fpage>–<lpage>894</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Bax1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bax</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ikeda</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fukui</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yaju</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tsuruta</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>More than numbers: The power of graphs in meta-analysis</article-title>. <source>American Journal of Epidemiology</source> <volume>169</volume>: <fpage>249</fpage>–<lpage>255</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Patsopoulos1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patsopoulos</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Evangelou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name> (<year>2008</year>) <article-title>Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation</article-title>. <source>International Journal of Epidemiology</source> <volume>37</volume>: <fpage>1148</fpage>–<lpage>1157</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Begg1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Egger1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Sterne1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sterne</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Gavaghan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Egger</surname><given-names>M</given-names></name> (<year>2000</year>) <article-title>Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature</article-title>. <source>J Clin Epidemiol</source> <volume>53</volume>: <fpage>1119</fpage>–<lpage>1129</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Chan1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Kwong</surname><given-names>YL</given-names></name> (<year>2005</year>) <article-title>Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes</article-title>. <source>Cancer Genetics and Cytogenetics</source> <volume>162</volume>: <fpage>10</fpage>–<lpage>20</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Xu1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>TJ</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Counterpoint: the myeloperoxidase -463G–&gt;a polymorphism does not decrease lung cancer susceptibility in Caucasians</article-title>. <source>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</source> <volume>11</volume>: <fpage>1555</fpage>–<lpage>1559</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Marchand1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marchand</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Seifried</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lum</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wilkens</surname><given-names>LR</given-names></name> (<year>2000</year>) <article-title>Association of the myeloperoxidase -463G-&gt; A polymorphism with lung cancer risk</article-title>. <source>Cancer Epidemiology Biomarkers and Prevention</source> <volume>9</volume>: <fpage>181</fpage>–<lpage>184</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Feig1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feig</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Loeb</surname><given-names>LA</given-names></name> (<year>1994</year>) <article-title>Reactive oxygen species in tumorigenesis</article-title>. <source>Cancer Res</source> <volume>54</volume>: <fpage>1890s</fpage>–<lpage>1894s</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Piedrafita1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Piedrafita</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Molander</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Vansant</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Orlova</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Pfahl</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element</article-title>. <source>J Biol Chem</source> <volume>271</volume>: <fpage>14412</fpage>–<lpage>14420</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-Chu2"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The MPO −463G&gt;A polymorphism and cancer risk: a meta-analysis based on 43 case–control studies</article-title>. <source>Mutagenesis</source> <volume>25</volume>: <fpage>389</fpage>–<lpage>395</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-2"><label>41</label>
<mixed-citation publication-type="book" xlink:type="simple">(2006) The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta GA.</mixed-citation>
</ref>
<ref id="pone.0065778-VanHelden1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Helden</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Keijer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Knaapen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Heil</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Briede</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Beta-carotene metabolites enhance inflammation-induced oxidative DNA damage in lung epithelial cells</article-title>. <source>Free Radic Biol Med</source> <volume>46</volume>: <fpage>299</fpage>–<lpage>304</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065778-VanSchooten1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Schooten</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Boots</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Knaapen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Godschalk</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Maas</surname><given-names>LM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Myeloperoxidase (MPO) -463G-&gt;A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>13</volume>: <fpage>828</fpage>–<lpage>833</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>